G2079 HCPCS code: Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2079 is the HCPCS Level II code for take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure. In 2024 Medicare paid an average of $69.57 per service for G2079 across 16,059 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 3 per day on outpatient hospital claims. Medicare volume rose 33% from 2022 to 2024 (12,047 to 16,059 services). In 2024, about 296 clinicians billed Medicare for G2079 for 997 beneficiaries; Ohio, Maryland, North Carolina accounted for 58% of services.
Code details
| Field | Value |
|---|---|
| Section | G codes — Procedures and professional services (temporary) |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 13 |
| BETOS category | M5D |
| Added | 2020-01-01 |
| Last action effective | 2020-01-01 |
Who bills G2079 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 296 |
| Medicare beneficiaries | 997 |
| States with claims | 18 |
| Share of services in top 3 states (Ohio, Maryland, North Carolina) | 58% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for G2079, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 12,047 | 816 | $77.67 | $76.82 |
| 2023 | 14,377 | 874 | $78.64 | $77.85 |
| 2024 | 16,059 | 997 | $70.30 | $69.57 |
States with the most G2079 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Ohio | 5,721 | $70.00 |
| Maryland | 1,617 | $68.59 |
| North Carolina | 1,149 | $69.40 |
| California | 1,101 | $69.51 |
| Virginia | 609 | $69.79 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 3 | CMS Policy |
| practitioner claims | 3 | CMS Policy |
Medicare policy articles for this code
- A59718: Billing and Coding: Opioid Treatment Programs (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (39 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| F11.10 | Opioid abuse, uncomplicated | 1 |
| F11.11 | Opioid abuse, in remission | 1 |
| F11.120 | Opioid abuse with intoxication, uncomplicated | 1 |
| F11.121 | Opioid abuse with intoxication delirium | 1 |
| F11.122 | Opioid abuse with intoxication with perceptual disturbance | 1 |
| F11.13 | Opioid abuse with withdrawal | 1 |
| F11.14 | Opioid abuse with opioid-induced mood disorder | 1 |
| F11.150 | Opioid abuse with opioid-induced psychotic disorder with delusions | 1 |
| F11.151 | Opioid abuse with opioid-induced psychotic disorder with hallucinations | 1 |
| F11.181 | Opioid abuse with opioid-induced sexual dysfunction | 1 |
Showing 10 of 39. The full list, non-covered diagnoses and CSV export are in Caduvo.
What changed for G2079
- 2020-01-01: G2079 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code G2079?
G2079 is the HCPCS Level II code for take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure. Short descriptor: "Take-hom buprenorphine".
How much does Medicare pay for G2079?
In 2024, the average Medicare payment was $69.57 per service (average allowed $70.30).
Does Medicare cover G2079?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for G2079?
Medicare policy articles that cite G2079 list 39 covered ICD-10-CM diagnosis codes across 1 article. The most cited include F11.10 (Opioid abuse, uncomplicated), F11.11 (Opioid abuse, in remission), F11.120 (Opioid abuse with intoxication, uncomplicated). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of G2079 can be billed per day?
3 on outpatient hospital claims; 3 on practitioner claims (NCCI medically unlikely edits).
Related G20 codes
- G2000 — Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session
- G2001 — Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2002 — Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2003 — Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2004 — Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2005 — Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2006 — Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2007 — Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2008 — Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2009 — Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)
- G2010 — Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment
- G2011 — Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under G2079
- Watch G2079 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for G2079
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.